Zosano Appoints New COO
This article was originally published in Scrip
Zosano Pharma Corporation, a clinical stage speciality company, has named Dr. Konstantinos Alataris to the newly created role of president and chief operating officer – effective Sep. 21, 2015. Alataris will replace current chief scientific officer and executive vice-president of R&D, Dr. Pete Daddona, who will be retiring Dec. 31, 2015.
Register for our free email digests: